Works by Yellon, DM

Results: 12

P437 Beta3-adrenergic receptor stimulation reduces ischemia/reperfusion injury through inhibition of the mitochondrial transition pore opening (mPTP) and subsequent apoptotic inhibition.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S80, doi. 10.1093/cvr/cvu091.116

By:

Garcia-Prieto, J;
Sanz-Rosa, D;
Pun-Garcia, A;
Villena-Gutierrez, R;
Bourio-Martinez, R;
Enriquez-Rodriguez, E;
Davidson, SM;
Fuster, V;
Yellon, DM;
Ibanez, B

Publication type:

Article

310 Plasma exosomes from rats and humans protect the myocardium from ischemia-reperfusion injury.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S56, doi. 10.1093/cvr/cvu090.3

By:

Vicencio, JM;
Zheng, Y;
Das, D;
Boi-Doku, C;
Sivaraman, V;
Hall, AR;
Yellon, DM;
Davidson, SM

Publication type:

Article

P445 The differential effects of Sirtuin-3 in cardio-protection.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S82, doi. 10.1093/cvr/cvu091.124

By:

Hall, A R;
Dongworth, RK;
Kumar, S;
Burke, N;
Yellon, DM;
Hausenloy, DJ

Publication type:

Article

P420 NAADP signalling augments ischaemia-reperfusion injury via two-pore channel 1 (TPC1).

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S77, doi. 10.1093/cvr/cvu091.100

By:

Foote, KK;
Zhao, YJ;
Graeff, RM;
Yellon, DM;
Davidson, SM

Publication type:

Article

P645 T2-mapping cardiac MRI for in vivo quantification of myocardial area-at-risk.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S117, doi. 10.1093/cvr/cvu098.71

By:

Dongworth, RK;
Campbell-Washburn, AE;
Roberts, T;
Yellon, DM;
Lythgoe, MF;
Hausenloy, DJ

Publication type:

Article

P653 Efficacy of remote ischaemic preconditioning in diabetic rats.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S119, doi. 10.1093/cvr/cvu098.79

By:

Harding, I;
Bell, RM;
Yellon, DM

Publication type:

Article

P443 Investigating coronary effluent transfer as a valid model of remote ischaemic conditioning: the role of stromal derived factor one alpha (SDF-1alpha) and nitric oxide.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S81, doi. 10.1093/cvr/cvu091.122

By:

Pickard, J M J;
Davidson, SM;
Yellon, DM

Publication type:

Article

P163 Stromal derived factor 1-a protects human heart tissue from simulated ischaemia-reperfusion injury.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S28, doi. 10.1093/cvr/cvu082.100

By:

Malik, A;
He, Z;
Sivaraman, V;
Davidson, SM;
Walker, JM;
Yellon, DM

Publication type:

Article

Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.

Published in:

British Journal of Pharmacology, 2012, v. 165, n. 5, p. 1235, doi. 10.1111/j.1476-5381.2011.01700.x

By:

Hausenloy, DJ;
Boston-Griffiths, EA;
Yellon, DM

Publication type:

Article

Remote ischemic conditioning: a clinical trial's update.

Published in:

2011

By:

Candilio L;
Hausenloy DJ;
Yellon DM;
Candilio, Luciano;
Hausenloy, Derek J;
Yellon, Derek M

Publication type:

journal article

Preconditioning the diabetic heart: the importance of Akt phosphorylation.

Published in:

2005

By:

Tsang A;
Hausenloy DJ;
Mocanu MM;
Carr RD;
Yellon DM;
Tsang, Andrew;
Hausenloy, Derek J;
Mocanu, Mihaela M;
Carr, Richard D;
Yellon, Derek M

Publication type:

journal article

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Published in:

2008

By:

Hausenloy DJ;
Yellon DM;
Hausenloy, D J;
Yellon, D M

Publication type:

journal article